Metabolic-Fit / 100
NewSelf review
⛔ FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront. The site also publishes its own named competitor-comparison pricing chart, claiming access to '1000+ physicians' across all 50 states and a signup-to-treatment window of as little as 4 days.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
NewSelf at a glance
- Semaglutide
- $99.97/mo
- Tirzepatide
- $144.49/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored NewSelf
Every factor comes from NewSelf's own published pricing, disclosures and oversight, and the six combine into the 48/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Fair pricing once you read past any teaser or plan structure.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
⛔ Added 26 August 2026: NewSelf Limited dba NewSelf holds FDA warning letter #721472, dated 20 February 2026. We confirmed it by reading the letter itself, which names newself.com. This review had been published for months without mentioning it. A letter discloses; it does not disqualify, and nothing about the ranking changed. $99.97 for semaglutide and $144.49 for tirzepatide, flat regardless of dose and confirmed on the homepage for all fifty states. The condition attached is the term rather than the price — three months up front, with no true month-to-month option.
What to expect when you sign up
We walked NewSelf's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage lists a real flat price for both molecules directly ('As Low As $99.97' semaglutide, '$144.49' tirzepatide), no intake required to see the numbers
- 2States 'Access board-certified doctors in all 50 states' and 'Get 3 months upfront — no delays, no refill hassles'
- 3Publishes its own competitor comparison chart naming several rivals' pricing and membership fees
- 4Claims 'signup to treatment in as little as 4 days' and '1000+ physicians'
What we noticed
- Flat, dose-independent pricing is stated explicitly and repeatedly for both molecules — 'One Price. Any Dose. Others charge more for higher doses — we don't'
- Requires 3 months upfront, which is a real commitment even though the per-month price is flat
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found on the pages checked
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99.97 | Semaglutide+, all dosages same priceIncludes B12 and glycine additives. 'All dosages are the same price' — no escalation as dose increases. |
| Compounded tirzepatide | $144.49 | Tirzepatide+, all dosages same priceIncludes B6 and glycine additives. 'All dosages are the same price' — no escalation as dose increases. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NewSelf's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Explicitly flat, dose-independent pricing for both molecules — a real differentiator most competitors don't offer
- Nationwide (all 50 states)
- Fast: signup to treatment in as little as 4 days, per the site
- Publishes its own named competitor-comparison pricing chart
The caveats
- ⛔ FDA warning letter #721472, dated February 20, 2026, to NewSelf Limited dba NewSelf, for false or misleading claims and misbranding — the letter names its own site
- Requires 3 months upfront rather than a true month-to-month option
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found on the pages checked
- No brand-name (FDA-approved) option and no oral form
NewSelf for mothers: our verdict
⛔ FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront. The site also publishes its own named competitor-comparison pricing chart, claiming access to '1000+ physicians' across all 50 states and a signup-to-treatment window of as little as 4 days. It runs about $99.97/month, flat across every dose — toward the affordable end of what we track.
We weigh NewSelf the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What NewSelf costs, in full
- Compounded semaglutide — Semaglutide+, all dosages same price: $99.97/mo
- Compounded tirzepatide — Tirzepatide+, all dosages same price: $144.49/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
NewSelf says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications NewSelf prescribes
NewSelf prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where NewSelf fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NewSelf is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a genuinely flat price that never climbs as their dose increases, and are comfortable prepaying 3 months.
Alternatives to NewSelf
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing NewSelf
Head-to-head & alternatives
NewSelf, answered
- How much does NewSelf cost?
- At last review, NewSelf's lowest ongoing compounded rate was about $99.97 a month — $99.97/mo for semaglutide, $144.49/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is NewSelf safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. NewSelf is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does NewSelf offer both semaglutide and tirzepatide?
- Yes — NewSelf offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does NewSelf rank for mothers?
- NewSelf scores 48/100 on our Metabolic-Fit Score and sits at #121. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect NewSelf's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.